PCC Exol SA

PCC Exol SA

GGPW:PCX
2.08
PLN
-0.02
(-0.95%)
0.26EPS
7.36P/E
330.86MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.71
2.96
2.98
3.13
3.63
3.69
3.7
3.74
4.65
6.78
5.45
5.44
6.23
6.58
Basic EPS, GAAP
0.05
0.02
0.09
0.12
0.11
0.11
0.16
0.23
0.33
0.69
0.24
0.2
0.22
0.26
Free Cash Flow per Basic Share
0.11
0.17
0.24
0.14
0.28
0.13
0.07
0.2
-0.11
0.51
0.27
0.14
0.2
0.37
Dividend per Share
0.01
0.02
0.01
0.04
0.13
0.09
0.09
0.05
0.17
0.12
0.1
0.07
- -
- -
Book Value per Share
1.26
1.28
1.38
1.49
1.41
1.46
1.54
1.73
1.91
2.49
2.61
2.73
2.9
3.08
Tangible Book Value per Share
0.09
0.1
0.19
0.3
0.24
0.27
0.34
0.53
0.7
1.28
1.39
1.51
1.69
1.87
Basic Weighted Avg Shares
172
172
172
172
172
172
173
173
173
174
174
174
174
174
Sales/Revenue/Turnover
467
511
515
540
625
636
639
646
807
1,181
948
948
1,086
1,145
Operating Margin (%)
5.76
3.71
5.93
5.51
5.14
5.27
6.46
8.83
9.62
13.5
7.55
6.26
5.99
6.14
Depreciation Expense
9
9
10
10
11
10
10
11
14
16
17
18
19
22
Net Income, GAAP
9
4
15
21
18
19
28
40
58
120
42
36
38
45
Effective Tax Rate (%)
26.17
30.55
22.31
3.1
9.25
9.9
13.74
18.58
19.73
18.87
16.28
15.36
14.73
13.44
Profit Margin (%)
1.95
0.79
2.86
3.98
2.91
3.06
4.43
6.23
7.19
10.13
4.45
3.75
3.49
3.92
Working Capital
42
52
31
62
54
38
-14
51
5
105
69
59
63
62
LT Debt
177
191
156
165
169
154
121
171
122
165
165
206
204
203
Total Equity
217
220
239
257
243
251
266
298
330
434
454
475
505
536
Return on Invested Capital (%)
4.89
3.1
5.39
6.56
6.31
7.33
8.14
9.94
11.51
21.71
8.42
6.88
7.12
7.5
Return on Capital (%)
4.64
2.85
5.33
6.64
6.08
6.57
8.29
9.7
12.03
22.09
8.43
6.84
7.06
7.49
Return on Common Equity (%)
4.69
1.84
6.42
8.67
7.29
7.88
10.93
14.25
18.46
31.28
9.5
7.66
7.74
8.77

Capital Structure

PLN

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
74
77
95
LT Borrowings
201
202
201
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
174
174
174
Market Capitalization
385
353
331

Working Capital

PLN

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
296
322
360
Cash, Cash Equivalents & STI
19
18
17
Accounts Receivable, Net
135
176
195
Inventories
132
112
133
Total Current Liabilities
233
267
298
Payables & Accruals
- -
- -
- -
ST Debt
74
77
95
Deferred Revenue
- -
- -
- -

Growth Rates

PLN

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.14%
11.55%
6.42%
Free Cash Flow
-64.83%
-155.98%
45.92%
Net Income, GAAP
20.14%
15.33%
6.58%
Sales/Revenue/Turnover
9%
13.21%
14.49%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
242
230
230
246
948
2025
290
270
271
255
1,086
2026
284
335
- -
- -
- -

Quarterly Earnings Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.05
0.04
0.07
0.2
2025
0.07
0.05
0.06
0.04
0.22
2026
0.04
0.12
- -
- -
- -

Quarterly Dividends Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.07
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Dariusz Ciesielski
Full Time Employees
336
Sector
Consumer non-durables
Industry
Household/Personal care
Address
ul. Sienkiewicza 4 Brzeg Dolny DS Poland 56-120
IPO Date
Aug 3, 2012
Business
PCC Exol S.A. manufactures and distributes a wide range of surfactants and specialized chemical formulations primarily for household chemicals, personal care products, cosmetics, textiles, industrial cleaning, plastics, construction, paper, metallurgy, pharmaceuticals, agrochemistry, paints and varnishes; the company offers anionic surfactants such as sulfonates, non-ionic surfactants including ethoxylates, amphoteric surfactants, and cationic surfactants, alongside flagship GREENLINE series eco-friendly products and modern industrial formulations with an annual production capacity exceeding 174,000 tonnes. Founded in 2008 and headquartered in Brzeg Dolny, Poland, near Wrocław, PCC Exol operates production facilities in Brzeg Dolny and Płock, serving over 1,000 customers across Europe, with subsidiaries including PCC Chemax Inc. in Piedmont, South Carolina, USA, and PCC Exol Kimya Sanayi Ve Ticaret Ltd. Sti. in Istanbul, Turkey; it functions as a subsidiary of PCC SE, leveraging the group's global network for research, development, and distribution while maintaining leadership in Central and Eastern Europe. Recent developments include the issuance and listing of Series E1 bonds in September 2025 to support financing needs, strong nine-month 2025 financial performance with sales of PLN 830.87 million and net income of PLN 30.99 million as of September 30, 2025, and ongoing investments in production capacity such as prior ethoxylation plant expansions in Płock since 2011, contributing to sustained growth amid challenging market conditions.